Approved Hospital Formulary
Add Formweb to your mobile device
Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.
Please be sure to document all clinical activities daily.
Approved Hospital Formulary
Search results for:
bendamustine
bendamustine
- Restricted Anti-Neoplastic Formulary
- Restricted Bendeka, Treanda, Vivimusta --> Restricted to Oncology and admin approval.
VIEW MORE Antineoplastic Agents
Last updated: Mar. 21, 2025
- HAZ-MED: Table 1
Treanda/Bendeka/Vivimusta are classified as formulary, restricted to oncology. Due to high cost, deferral to the outpatient setting should be explored. If ordered, contact a member of pharmacy administration.
Treanda, Bendeka, and Vivimusta are classified as therapeutically equivalent and interchangeable. The most cost-effective agent will be utilized.
Reviewed: July 29, 2008 & 22 March 2016 (Bendeka), February 2025 (Vivimusta)
Bendamustine (Vivimusta) Spotlight